184 related articles for article (PubMed ID: 8836890)
1. Hepatitis C infection and autoimmunity.
Eddleston AL
J Hepatol; 1996; 24(2 Suppl):55-60. PubMed ID: 8836890
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune hepatitis and/or hepatitis C].
Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
[TBL] [Abstract][Full Text] [Related]
4. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
5. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Lunel F; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
[TBL] [Abstract][Full Text] [Related]
7. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
8. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
9. Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity.
Vianello F; Tison T; Tagariello G; Zerbinati P; Zanon E; Scarano L; Girolami A
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):393-7. PubMed ID: 10493222
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
11. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
13. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
[TBL] [Abstract][Full Text] [Related]
14. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
[TBL] [Abstract][Full Text] [Related]
16. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
17. [Extrahepatic manifestations of HBV and HCV infection].
Hartmann H
Praxis (Bern 1994); 1997 Jul; 86(29-30):1163-6. PubMed ID: 9333915
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
19. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmunity and HCV].
Bianchi FB
Recenti Prog Med; 1993 Nov; 84(11):774-8. PubMed ID: 8290791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]